Skip to main content
. 2008 Oct;62(10):1547–1559. doi: 10.1111/j.1742-1241.2008.01880.x

Figure 4.

Figure 4

Odds of developing a vascular-related adverse event while on specific α1-adrenergic receptor blockers. Sizes of the data markers are indicative of the relative weight of each study. The bar is representative of the 95% confidence interval